scholarly journals Variation in Serum PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9), Cardiovascular Disease Risk, and an Investigation of Potential Unanticipated Effects of PCSK9 Inhibition

2019 ◽  
Vol 12 (1) ◽  
Author(s):  
Ben M. Brumpton ◽  
Lars G. Fritsche ◽  
Jie Zheng ◽  
Jonas Bille Nielsen ◽  
Maria Mannila ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Proprotein Convertase ◽  
Pcsk9 Inhibition

scholarly journals PCSK9 inhibition to reduce cardiovascular disease risk

2015 ◽  
Vol 22 (2) ◽  
pp. 126-132 ◽  
Author(s):  
Hagai Tavori ◽  
Ilaria Giunzioni ◽  
Sergio Fazio
Keyword(s):  
Cardiovascular Disease ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Pcsk9 Inhibition

Oral contraceptives and cardiovascular disease risk in black and white women:

2001 ◽  
Vol 01 (4) ◽  
pp. 175-183
Author(s):  
Kate Wheeler ◽  
Cora E. Lewis ◽  
Dale Williams ◽  
Stephen Sidney ◽  
Catarina I. Kiefe ◽  
...  
Keyword(s):  
Cardiovascular Disease ◽  
Oral Contraceptives ◽  
White Women ◽  
Disease Risk ◽  
Cardiovascular Disease Risk ◽  
Black And White
Sign in / Sign up

Export Citation Format

Share Document